Sunday, 23 February 2020

Pharma News

  • Alexion to acquire Synageva biopharma for $8.4 bn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2015

    Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based Synageva is a biopharmaceutical company dedicated to discovering, deve...Read more

  • Director resigns at China Nepstar Chain Drugstore

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest drugstore chain in China based on the number of directly operated stor...Read more

  • DKSH expands in Hong Kong

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2012

    Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nong's, traditonal chinese medicine...Read more

  • Innovative dual chamber syringe for pharma market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceutical...Read more

  • Indian FIPB clears pharma FDI proposals worth $536 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has cleared eight of the ten pending proposals of foreign drug firms tha...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • Agnitio expands in China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global presence with the opening of regional headquarters in Shanghai and a part...Read more

  • Takeda to acquire LigoCyte Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have en...Read more

  • Ranbaxy, Gilead sign licensing agreement

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtrici...Read more

  • Universities get $15mn from Teva for CNS R&D

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Israel-based Teva is undergoing re-organization in order to mitigate lost revenue from increased competition from copies of its best-selling branded multiple sclerosis drug, Copa...Read more

  • NSF brings Secondary Reference Standards to India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary suppleme...Read more

  • Takeda, Resolve to develop, sell autoimmune drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the treatment of lupus (also known as systemic lupus erythematosus or SLE)...Read more

  • Bayer initiates Phase II/III trial of a new compound for Hemophilia A

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Malaysia a hotbed for medical tourism'

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Medical tourism, easy regulatory guidelines, a lack of strict price regulation and an increasing elderly population will be the main contributors to the rapid rise in Malaysia's ...Read more

  • R-Tech Ueno loses case against Takeda

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceut...Read more

  • APAC ovarian cancer drug market to grow modestly'

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more